News
The latest international news, investigations and analysis from Africa, the Americas, Asia, Australia, Canada, Europe, the Middle East and the U.K.
AstraZeneca joins KRAS push in cancer with Chinese deal AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova for $24 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback